A new study details the call burden on U.S. Poison Control Centers of both unintentional and intentional exposures to medications used to treat attention-deficit/hyperactivity disorder. Just substitute the substance and read why it's the same story, just a different day.
Ritalin, a staple for the treatment of ADHD in children, is the subject of a new Cochrane Report questioning its effectiveness. The review, which also contains caveats that somewhat undercut its primary finding, indicates that the widely-used drug may have a better reputation than it deserves.